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                                 Abstract 
 
Aim : 
 The aim of the is to study the prevalence of cord blood parasitaemia in maternal fever 
and its outcome in the health of the newborn.  
Method :  
The study was conducted during the months of February to September , 2015 at 
Institute of Gynaecology, Chennai. The study was done among 100 newly delivered 
babies whose mothers had history of fever during the antenatal period. One ml of cord 
blood was collected from the umbilical vein and stored in EDTA tubes. Thin and 
thick smears  of cord blood were prepared and  examined by an experienced personnel 
for cord blood parasitaemia. They were then followed for organomely , fever , 
jaundice, anaemia & birth weight monitored. Repeat smear was taken from babies 
showing any of the symptoms. 
Results :  
No sample tested positive for cord blood parasitaemia. Maternal malaria was reported 
from 6 mothers. (6%) Three babies were of LBW and  two were preterms among 
mothers with maternal parasitaemia.  A total of 28 babies showed systemic 
manifestations among smear negative mothers. Among these none of them tested  
positive for cord blood parasitaemia repeat smear. 
Conclusion : 
 
The study has shown no prevalence of cord blood parasitaemia.  The study 
recommends to conduct more studies on neonatal outcomes of maternal malaria with 
different diagnostic modalities in Indian setup. 
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INTRODUCTION 
 
A worldwide infectious disease shrouding the multitude of countries 
inhabiting the tropics and sub-tropics, Malaria poses as an acute and 
complicated health setback. Related to lack of development, poverty, 
insufficient resources and general unawareness, this protozoal disease 
continues to play an undeniable role in the staggering rate of the overall 
infectious disease-related mortality and morbidity in the world. The countries 
particularly affected are Africa, the Mediterranean States, S-E Asia, and some 
areas of South America. (1) 
Malaria affects all the 6 major regions of the world, putting more than 
3 billion individuals spanning over almost 100 countries and territories at a 
threat of being infected with the parasite and developing the disease (as 
shown in Map 1). Almost 1.2 billion people are at a higher risk (more than 1 
in 1000 likelihood of contracting the disease in a year).  
 
The most recent estimates of the year 2013 reported 198 million 
malaria cases worldwide. The disease has resulted in 584,000 deaths the 
same year. Since the year 2000, a decline in the mortality rate of forty-seven 
percent and in the incidence rate of thirty percent has been seen.  
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Africa has reported the highest affliction of malaria. Ninety percent of 
all malarial deaths are known to occur in Africa alone and children under 5 
years account for seventy-eight percent of all deaths. (2)  
Deaths in childhood is mostly due to cerebral malaria and anaemia. 
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Map 1: Map showing worldwide distribution of malaria 
(adapted from WHO 2014) 
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Around twenty-seven percent of the total population in India live in 
areas of high transmission (more than 1 case per 1000 population). Fifty-
eight percent of the population live in areas of low transmission (1 – 2 case 
per 1000 population).  Ninety-two percent of malaria cases in India occur in 
the states of Chhattisgarh, Jharkhand, Madhya Pradesh, Orissa, Maharashtra, 
Gujarat, Northeast, Rajasthan and West Bengal. 
 
The disease is characterized by paroxysms of fever with chills, rigor, 
fatigue, anaemia and hepatosplenomegaly. Classical malaria consists of three 
distinct stages i.e. the cold stage, hot stage and the sweating stage. These 
events are followed by an afebrile phase bringing great relief to the patient. 
The clinical manifestations may vary from mild to severe and complicated 
depending on the species and the person’s immunity. 
 
The disease is transmitted by the bite of an infected female 
Anopheles mosquito (Figure 1). 
 
  
 
 
- 5 - 
 
Malaria in humans is caused by the four distinct species of 
Plasmodium which include the (Figure 3): 
 
 Plasmodium falciparum 
 
 Plasmodium vivax 
 
 Plasmodium malariae 
 
 Plasmodium ovale. 
 
Plasmodium falciparum which is known to be more dangerous than 
the other species, is primarily responsible for the most severe malaria cases 
and deaths related to it. (3) 
Ninety percent of global malaria-related deaths have been known to 
occur in the sub-Saharan Africa regions, which has the highest burden. 
Plasmodium falciparum is the prime species here.  
Several studies have reported that Plasmodium Vivax is the prime 
species affecting the regions around Southeast Asia and America. (4) It is 
also known to have the highest geographical distribution across the world 
over. 
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Figure 1: Female Anopheles Mosquito 
 
 
 
Female Anopheles mosquitoes are the vectors for malaria. 45 species 
are known to exist. A minimum of 12 days is required to become infective. 
Their breeding habitats also vary. The breeding areas include moving water, 
brackish water, wells and cisterns. They are nocturnal in their habits. (5) 
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LIFE CYCLE OF PLASMODIUM 
 
 
 
Plasmodium undergoes 2 cycles of development in two different hosts 
– one in the human (asexual form) and the other in the mosquito (sexual 
form). Humans are the intermediate host where they replicate in numbers 
whereas the mosquito is the definite host where they undergo sexual 
maturation (as shown in Figure 2). 
 
 
The life cycle of a plasmodium can be explained as such:  
 
 the hepatic phase,  
 the erythrocytic phase and 
 the gametogeny. 
 
HEPATIC PHASE 
The malarial parasite resides in the gut and salivary glands of an 
infected female mosquito. Infection is transmitted to humans when an infected 
mosquito bites and injects sporozoites into the human bloodstream. The 
sporozoites soon disappear within 60 minutes from peripheral circulation and 
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then invade the liver. Circumsporozoite protein (CS), the surface proteins, 
mediate hepatocyte invasion. 
Sporozoites go through asexual reproduction and develop into schizonts 
over 1 – 2 weeks. Schizonts are known to contain thousands of 
merozoites. Number of merozoites within schizonts varies. Each Plasmodium 
falciparum sporozoite can contain up to 40,000 merozoites.  There are no 
clinical symptoms during this phase.  
 
ERYTHROCYTIC CYCLE 
 
A mature schizont ruptures releasing merozoites into circulation.  Soon 
it attaches itself to erythrocytes.  Within the RBC, it consumes Hb for energy, 
and then transforms itself into trophozoites. It again forms schizonts and begins 
another cycle of asexual reproduction, producing up to 36 merozoites per 
schizonts. The schizont ruptures releasing merozoites into circulation again, 
thereby infecting the rest of the RBCs.  
The whole process of infection, multiplication, and rupture goes on and 
on till it is subdued by the immune system. This phase is associated with 
systemic manifestations.  
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SPOROGONIC CYCLE 
 
In all species of malaria, the erythrocytic forms fail to divide. They only 
differentiate into male and female gametocytes which are taken in by a 
mosquito during a blood-meal. Fertilization of gametocytes occur within the 
stomach of mosquitoes forming zygotes. These zygotes then develop into 
motile and lengthened ookinetes, which penetratethe mosquito’s mid-gut wall 
to develop into oocysts.   
The oocysts then rupture releasing sporozoites that later reach salivary gland of 
the mosquitoes.  This cycle can repeat again once the mosquito feeds on 
another human host during a blood-meal.   
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Figure 2:  Life Cycle of Plasmodium Species 
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Figure 3: Plasmodium Species 
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Most malarial deaths have been reported among infants and young 
children. The population groups that are most at risk to malaria are the 
children and the pregnant women.(6)Pregnant women are more vulnerable to 
its adverse effects because of their reduced natural immunity.(7) 
Malaria continues to pose as a public health problem as its 
consequences in pregnancy are grave for both the mother as well as the child. 
The adverse impact on new-borns start before the child is born. 
 
“Congenital malaria denotes the occurrence of asexual 
forms of malarial parasites in the peripheral blood  
film of a neonate within the 1st seven days of life.” 
 
Its risk factors include 
 
 maternal peripheral parasitaemia, 
 placental parasitaemia and 
 
 cord blood parasitaemia. (8) 
 
Parasitaemia in the cord blood is known to have great association with 
peripheral parasitaemia in the neonates. A latest review of congenital malaria 
deemed the presence of cord blood parasitaemia to be a category of the 
definition of congenital malaria .(8) 
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CONGENITAL MALARIA 
 
 
 
The true incidence of congenital malaria remained a controversial issue 
for many years as many had reported it to be a very infrequent occurring. (9) 
However, in the year around 1980, a low incidence of congenital malaria had 
been reported from Africa. The occurrence of malarial parasite in the cord 
blood or the neonatal blood was determined to be insignificant. Also very less 
infants developed symptoms of congenital malaria.(10)  
 
The resistance to transmission of congenital malaria is offered by: 
 
 the placenta acting as a physical obstruction to block the infected 
RBCs,  
 the transfer of maternal antibodies and 
 high foetal Hb composition and relatively lower free O2tension. 
 
All these factors provide poor survival conditions for plasmodial 
growth.(11) A number of cross-sectional studies conducted on congenital malaria 
within the last twenty years indicated that it is not as uncommon as was 
initially speculated.  
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A close relationship between the placental parasitaemia and the cord 
blood parasitaemia was demonstrated, which was felt to contribute to its 
occurrence. 
 
‘A study from Kenya by Malhotra et al had reported that the malarial 
parasites recovered from the cord blood were acquired transplacentally and 
primis were at much higher risk for congenital infection.(11) The finding 
further contradicted the earlier studies of its low occurrence and supported that 
the placental transmission of malaria was more frequent and the placental 
obstruction is not very effective to restrict its transmission.’ 
 
A number of factors have been reported to influence its estimation.  
 
These factors include: 
 
 difference in understanding the criteria for defining  
 
congenital malaria; 
 
 resistance of mothers to infection; 
 
 source from where the blood samples were taken  
 
for smear examination (neonatal or cord blood);  
 
 the experience and reliability of peripheral smear 
 
examinations by the trained medical personnel; 
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 the technique used for parasite detection ( Giemsa 
 
staining with smear examination or PCR). (12) 
 
 
Failure to consider these factors could lead to its underestimation. 
Therefore, these influencing factors must be taken into consideration so as to 
avoid the false estimation of its prevalence. (12)  
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MECHANISM OF CONGENITAL MALARIA 
 
 
The mechanism involving the passage of the malarial parasite from 
infected mothers to their newly born infants is still not clearly understood. 
Possible mechanisms that could be involved include: 
 
 organisms directly penetrating through the chorionic villi, 
 untimely placental-separation, and  
 the likelihood of the mother’s RBCs gaining entry into the foetal 
circulation in utero or during labour. 
 
Many features that openly effect this rate include:  
 
 resistance of mothers to malaria infection, (13)  
 
 severity of malaria during pregnancy, (14) 
 
 lack of immunity among mothers, (15) 
 
 placental parasitaemia among primi and  
 
multigravida and  
 
 HIV infection among mothers. (16) 
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CLINICAL FEATURES 
 
The typical clinical symptoms usually occur after the first seven days of the 
neonate’s life (but has been reported on the first day aswell). The most 
common clinical manifestations in most of the cases include (17) 
 
 pyrexia, 
 
 anaemia and 
 
 organomegaly. 
 
 
These symptoms may be observed right after birth but in some cases 
there might be a delay for a number of weeks or even more. 
 
The affected new-borns may also present with (17) 
 
 
 jaundice,   
 
 regurgitation, 
 
 loose stools,  
 
 decreased intake of feeds and  
 
 lethargy and cyanosis can also be seen. 
 
 
There may at times be delay in the onset of symptoms in the affected    
new-borns. This could partly be due to the factors that may provide protection  
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to the new-borns  initially ,especially those being delivered by women 
living in endemic zones. The factors could be foetal Hb , haemoglobinopathies 
providing resistance ,the emission of white blood cells or toxic substances 
derived from macrophages which cross the placenta into foetal circulation and 
anti-malarial therapy taken by mothers during pregnancy.(17) 
 
 
Poor fetal growth, low birth weight, pre-term delivery, miscarriage, 
stillbirth and malnutrition during infancy have also been associated. (18) 
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CONGENITAL MALARIA- DIAGNOSIS 
 
 
Timely and exact identification of congenital malaria and suitable 
intervention is mandatory in dealing with this issue. Many cases of congenital 
malaria go undiagnosed due to absence of specific symptoms. (19)  
 
 
Malaria is diagnosed by the examination of parasites under the 
microscope on Giemsa-stained blood smears (both peripheral thick and thin 
blood smears) (Figure 4). Microscopy is the most widely used technique in all 
malaria affected areas for the diagnosis. 
 
A good clinical examination and follow up, a high index of suspicion 
and peripheral blood smear examination by an experienced personnel is 
essential for the accurate diagnosis of congenital malaria. (20) 
 
Plasmodium antigen detection  (polymerase chain reaction) of the blood 
and rapid diagnostic tests (Figures 5 and 6) are other alternative methods that 
give good results. 
 
Histopathological examination of the placenta can also be employed. (8) 
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Figure 4: Thick and Thin Peripheral Smears 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Rapid Diagnostic Kit 
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Figure 6 Rapid Diagnosis Of Malaria By Rdts Test Kit 
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TREATMENT OF CONGENITAL MALARIA 
 
 
Though a number of latest studies have given an idea about the proper 
and efficient management of congenital malaria, there is evidently no defined 
guidelines for the treatment of congenital malaria. (21) 
 
Menendez & Mayor (2007) emphasized in their report that it would be 
constructive on one’s part to differentiate between babies delivered to immune 
and non – immune mothers, and all symptomatic cases should be treated with 
quinine at a dosage of 10 mg/kg /8 hours orally or  in same dosage in IV form 
till it can be administered orally. (12)  
 
Chloroquine-resistant congenital malaria has been reported in a number 
of studies.  
 
Quinine with Clindamycin was recently stated for proving useful in the 
treatment of Plasmodium Falciparum congenital malaria. Chloroquine was 
considered to be effective for the treatment of Plasmodium Vivax infection. (22) 
 
For complicated cases one should consider intravenous quinine or 
intravenous artesunate. 
 
An Indian study observed that a case of congenital malaria which 
showed no response to chloroquine, showed good response to artesunate. (23) 
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Chloroquine had been the first line of treatment for many years and the 
ever increasing resistance to it has prompted many to consider research on the 
effectiveness of other antimalarial drugs.  
 
A study done in China, while making a comparison between the 
effectiveness of artesunate with that of quinine in the treatment of congenital 
malaria showed artesunate being superior to quinine and concluded that one 
can consider it as a first line drug. (24) 
 
However , more studies are needed to further explicate the effectiveness 
of artesunate in the treatment of congenital malaria. 
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AIMS AND OBJECTIVES 
 
AIM: 
 
To study the prevalence of cord blood malarial parasitaemia in a malaria  
endemic zone. 
 
OBJECTIVES: 
 
1. To determine the prevalence of cord  blood parasitaemia in a sample of 
100 pregnant women reporting with fever around the time of delivery. 
 
2. To assess neonatal outcome in terms of parity of mother, birthweight of 
newborn, gestational age, systemic manifestations such as fever, 
jaundice, organomegaly , anaemia. 
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STUDY JUSTIFICATION 
 
 
 The population groups that are most at risk to malaria are children and 
pregnant women. (7) 
 Pregnant women are vulnerable because of their reduced natural 
immunity. (8) 
 Its consequences start before the child is born.  
 Congenital malaria has been documented in malaria endemic areas for 
many years.  
 The clinical symptoms are normally observed after the first seven days 
of neonatal life (though it has been observed to manifest on the first day 
as well ). These include fever, anaemia, jaundice, hepatosplenomegaly 
lethargy, poor feeding, drowsiness, irritability etc. (17) 
 Poor foetal growth, low birth weight, pre-term delivery, miscarriage, 
stillbirth, malnutrition during infancy have been associated. (17) 
 
 Congenital malaria is considered to be the least known manifestation of 
malaria. (12) 
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 Most of the current studies are based on cases of babies delivered by 
non-immune mothers. (34) 
 
 It was assumed that children below six months of  age were 
comparatively more guarded against malaria due to presence of 
mother’s immunoglobulins and foetal Hb.  
 
 
 Several cross-sectional studies conducted within the last twenty years 
showed that it is not as rare as was formerly speculated. 
 
 Current knowledge is mostly limited to African studies.  
 
 
 A study done at a tertiary centre in hyper endemic zone in Central India 
has reported some incidence of congenital malaria and emphasized the 
need to conduct more studies in the Indian setup. (7) 
 
 In India, Chennai city has been an endemic area for malaria.  
70 percent of the malaria cases in Tamil Nadu were recorded only from 
Chennai. 
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 There is a need of considering it as differential diagnosis to avoid its 
adverse consequence. (25) 
 
 So this study aims to find out the prevalence of cord blood parasitaemia 
& its consequences on the health of the newborn. 
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OBJECTIVES:  
 
To find out the incidence of congenital malaria in a   group of pregnant 
women in a hyper-endemic area of central India.  
 
To determine the placental weight and parasitaemia, and to assess its 
outcome in terms of survival, mean hemoglobin and mean birthweight in 
newborns. 
 
STUDY DESIGN:  
Prospective observational study. 
 
PLACE: 
Maternity and neonatal ward of a tertiary level Hospital attached to a medical 
college located in Rewa , Madhya Pradesh, INDIA. 
 
 
SAMPLE SIZE: 200 
   
The study was done among term primis admitted in  the maternity ward and 
their newborns. 
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RESULTS: 
 
Out of 70 infected mothers, only 6 (2.95%) neonates had parasitaemia. 
Birth weight was less in the exposed group. Difference in the proportion of 
preterm babies , incidence of still birth and early neonatal death were not 
significant among the exposed and unexposed group. 
 
CONCLUSION: 
 
The study showed a low incidence of congenital malaria low in spite of 
high maternal parasitaemia. Need to consider more studies in the Indian setup. 
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The study was conducted at Government Medical College  
and Hospital in Jabalpur, Central India 
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SAMPLE:  
 
The study was done among pregnant women with gestational age from 12 
week’s gestation up to 40 days after delivery. The study was carried out on 
women with a history of fever. 
 
 
 
RESULTS:  
 
365 mothers were found to be infected.  
155 neonates weighed 500 g less than non-infected. 
3% abortion, 3.7% stillbirths and 2% neonatal deaths were reported. 
 
CONCLUSION:                      
The study concluded that pregnant women residing in the area have increased 
susceptibility to malaria infection during pregnancy and puerperium. 
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Catherine O. Falade, Olukemi O. Tongo, Oluwatoyin O. Ogunkunle, Adebola 
E. Orimadegun. 
 
 
PLACE:  
 
The study was conducted in secondary Health Care  
 
Centres in Ibadan, southwestern Nigeria. 
 
 
 
SAMPLE: 
 
Study was conducted among 983women attending  
 
antenatal clinic and their newborns. 
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RESULTS: 
 
 Prim gravida had higher incidence of placental parasitaemia. 
 Placental, maternal and combined placental and maternal malaria were 
13.1%, 12.7% and 11.1% respectively.  
 Mothers with parasitaemia delivered more babies with LBW and a lower 
mean length. 
 
 
 
 
CONCLUSION: 
 
 
Maternal parasitaemia results in symmetric foetal growth retardation.  
The incidence placental parasitaemia is more among primis. 
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AIM: 
 
Impact of maternal, placental and cord blood parasitaemia  
 
on the birth weight of newborns. 
 
 
PLACE:  
 
Mutengene Maternity Centre, Fako Division, South West   Province, 
Cameroon. 
 
STUDY DESIGN: 
 
Observational cross-sectional study 
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METHOD:  
 
770 parturient women were considered in the study .The presence of 
maternal, placental and cord blood parasitaemia was determined by light 
microscopy .Blood samples were collected between June 1999 and September 
2001. The birthweights of their newborns were recorded immediately. 
 
 
RESULTS: 
 
Malaria parasitaemia were present in 7.8 percent, 32.8 percent and 33.7 
percent cord, maternal and placental biopsies respectively. 
Newborns from malaria positive cases had higher 
 
incidence of LBW. 
 
CONCLUSION:  
 
Maternal malaria parasitaemia has a negative impact on birthweight of 
their newborns.  
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PLACE: 
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Cross-sectional study. 
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SAMPLE: 
 
The study enrolled 100 women attending ANC and their newborns. 
Their placenta and the cord blood of their newborns were examined for 
parasitaemia. 
 
 
RESULTS: 
 
The incidence of congenital malaria was 16/104 (15.3%). 
 
 
CONCLUSION: 
 
Congenital malaria is not a rare entity. 
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AIM: 
 
Find out the prevalence and pattern of umbilical cord blood malaria in a family 
practice setting in sub-Saharan Africa. 
 
METHODOLOGY: 
 
A prospective case study of pregnant women at delivery was done in a 
private practice setting in sub-Saharan Africa.  Smears prepared from maternal 
peripheral blood and umbilical cord blood were examined under light 
microscope for malarial parasites. 
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RESULT: 
 
Prevalence of cord blood malaria was 64.6% compared with 68.8% for 
maternal blood. 
Primis had the highest prevalence of parasitaemia.  
 
CONCLUSION: 
 
There exists a close association between placental malaria and umbilical 
cord parasitaemia. 
Primis are more prone to a higher prevalence of parasitaemia. 
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AUTHORS : Oringanje C, Meremikwu  
M, Ogar B, Okon A, Udoh A. 
 
 
AIM:  
 
To evaluate the status of malaria in pregnancy in Cross River State, 
Nigeria. 
 
 
METHOD: 
 
Maternal, placental and cord blood samples were collected and 
examined for malaria parasites by light microscopy. 
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RESULTS: 
 
Out of the total 120 (19.2%), 69 (14.7%) and 62 (13.5%), respectively, 
had positive maternal, placental and cord blood parasitaemia.  
 
 
 
CONCLUSION: 
 
The prevalence rates of parasitaemia at delivery indicate there is a high 
rate of malaria transmission from mothers to their newborns. 
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                             METHODOLOGY 
 
 
STUDY DESIGN 
 
                   Observational Cross Sectional Study    
 
 
PLACE OF STUDY 
                  
                   Institute Of Gynaecology, CHENNAI 
 
 
TIME OF STUDY 
 
                   FEBRUARY 2015 TO SEPTEMBER 2015 
 
 
SAMPLE SIZE 
 
                    100 
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INCLUSION CRITERIA            
 
Newly delivered babies of mothers who were admitted with history of 
fever.  
 
 
EXCLUSION CRITERIA  
 
 
 Mothers with known medical conditions. 
(such as cardiac diseases, pulmonary diseases, hypertension, renal  
diseases, HIV infection, cancer, diabetes) were not included.  
 
 
 
 Newborns with birth asphyxia and  
 
 Newborns with congenital malformations. 
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                                ETHICAL ISSUES 
 
 
 
 A written , informed consent was taken from each pregnant mother and 
her spouse when she got admitted in the ward. 
 
 Approval for conducting the study was procured before initiation of the 
study from Departmental Ethics Committee. 
 
 All the participants were given the choice to leave the study at any time 
during their hospital stay if they so wished. 
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STUDY MANEUVER 
 
The study was conducted during the months of February to September 
2015 in the Maternity and Neonatal Wards of Institute of Obstetrics & 
Gynaecology, a tertiary health centre attached to Madras Medical College in 
Chennai, Tamil Nadu. 
 
 
Chennai is considered to be one of the endemic areas for malaria in the 
southern Indian state of Tamil Nadu.  
 
Pregnant women admitted in the Annexe labour wards were approached. 
Mothers with history of fever during the antenatal period were enrolled in the 
study. A written, informed consent was procured from each of these parturient 
mothers and her husband when she got admitted in the ward. The study 
required inclusion of all newborn babies admitted with history of maternal 
fever. Mothers with any known medical disorder were excluded from the study. 
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SPECIMEN COLLECTION 
 
 
 
The study involved collection of one millilitre of  cord-blood from the 
umbilical vein at the time of delivery. Each millilitre of cord-blood was 
accumulated and kept in  EDTA Tubes (Figure 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: EDTA tubes used for Sample Collection 
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LABORATORY METHODS 
 
 
 Thin and thick films of cord blood were made on clean microscope 
slides and were then dried in the air.  
 
 Both thin and thick smears were stained using Giemsa stain.  
 
 The thin smears were methanol-fixed before staining.  
 
 The slides were instantly labelled. 
 
 The smears were viewed at X 100magnification under oil immersion 
objective by a trained medical personnel.  
 
 The detection of asexual stages of the parasite on the thick films was 
counted as a positive diagnosis. The thin films helped to determine the 
species.  
 
 A negative diagnosis was judged  if no parasite could be determined 
after checking  500 White Blood Cells. 
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 Blood samples were not drawn from all the babies ( except from the 
ones who showed systemic manifestations and were subsequently 
followed up).  
 
 
 
 
 
 
 
               Figure 8: Thin and thick smears prepared from cord blood 
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CLINICAL EVALUATION 
 
 
All babies were seen and assessed.  
 
The gestational age of the newly born babies were determined using the 
Ballard scoring system (through neuromuscular and physical assessment of 
newborn) and by the history of last menstrual period.  
 
      I :  Preterm: A gestational age of less than 37 weeks  
Term: A gestational age between 37 and 42 weeks   
Post term: A gestational ageover 42 weeks Birth weight of each baby 
was recorded.  
      
      II : LBW:  Birthweight less than 2.5 kg at birth was considered to be low    
birth weight 
Normal  : Birthweight between 2.5 kg and 3.5 kg at birth was considered 
to be normal birth weight  
HBW: Birthweight more than 3.5 kg at birth was considered to be high 
birth weight. 
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The rectal temperature of the babies was taken using a digital 
thermometer. Fever was considered to be present when temperature > 38 
degree Celsius.  
 
 
Neonates were followed up for organomegaly, jaundice, fever, anaemia 
and features of lethargy/poor feeding. A repeat peripheral smear examination 
was done to look for malarial parasites from all the babies showing any of these 
symptoms. 
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Figure 9: New Ballard score 
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RESULTS AND ANALYSIS 
 
Data was collected in a planned form and was regularly recorded and 
revised in a Microsoft Excel data sheet.  Data was analyzed using SPSS 16.0. 
and OPEN epl version for statistics. 
 
A total of 100 patients were included in the study sample. All infants 
with history of maternal fever who satisfied the inclusion criteria were included 
in the study group. 
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Table 1: Table for Maternal Fever 
 
 
Table 2: Table for Cord Blood Parasitaemia 
 
 
100 samples of cord blood were procured and investigated for 
parasitaemia.  
Malarial parasites could not be detected among the cord blood samples 
examined, though six mothers had reported with malaria parasite peripheral 
smear  positive. 
 
 Frequency Percent Valid Percent Cumulative Percent 
Valid YES 100 100.0 100.0 100.0 
 Frequency Percent Valid Percent Cumulative Percent 
Valid NEGATIVE 100 100.0 100.0 100.0 
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Table 3: Table for Gravida of Study Sample 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
VALID 
G2P1L1 35 35.0 35.0 35.0 
G3P1L1A1 4 4.0 4.0 39.0 
G3P2L1 3 3.0 3.0 42.0 
G3P2L2 11 11.0 11.0 53.0 
G4P3L1 1 1.0 1.0 54.0 
G4P3L2 2 2.0 2.0 56.0 
PRIMI 44 44.0 44.0 100.0 
TOTAL 100 100.0 100.0  
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Among the 100 mothers enrolled in the study sample, maximum were 
primigravida. 
This was followed by gravida 2 para 1.  
Mothers with gravid 3 were less than 20. 
Among the 6 cases of maternal malaria detected, 3 were primigravida 
and 3 were multigravida.  
The infants were followed up for symptoms of congenital malaria.  
They were examined for the presence of jaundice, fever, anaemia and 
organomegaly. 
Gestational age and birthweight of the newborns were also taken in 
account. 
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Table 4: Table for Neonatal Jaundice 
 
 
Jaundice was reported from 7 out of the 100 children included in the 
study. 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
Absent 93 93.0 93.0 93.0 
Present 7 7.0 7.0 100.0 
Total 100 100.0 100.0  
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 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
Absent 92 92.0 92.0 92.0 
Present 8 8.0 8.0 100.00 
Total 100 100.0 100.0  
 
Table 5: Table for Fever 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fever was reported from 8 out of the 100 children  
included in the study. 
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 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
Absent 95 95.0 95.0 95.0 
Present 5 5.0 5.0 100.0 
Total 100 100.0 100.0  
 
Table 6: Table for Organomegaly 
 
 
Organomegaly was reported from 5 out of the 100 children  
included in the study. 
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 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
Absent 90 90.0 90.0 90.0 
Present 10 10.0 10.0 100.0 
Total 100 100.0 100.0  
 
Table 7: Table for Anaemia 
Anaemia was reported from 10 out of the 100 children  
included in the study 
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 Frequency Percent Valid Percent Cumulative Percent 
Valid 
Boy 60 60.0 60.0 60.0 
Girl 40 40.0 40.0 100.0 
Total 100 100.0 100.0  
 
Table 8: Table for Gender of New-borns 
 
 
Out of the 100 babies delivered, 60 of the total were boy babies (60%) and the 
remaining 40 (40%) were girl babies. 
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 N Minimum Maximum Mean Std. Deviation 
Maternal Age 
(in years) 
 
100 18 35 24.88 3.851 
Gestational Age 
(in weeks) 
 
100 29 41 36.44 2.709 
Birth Weight (in kg) 
 
100 .98 3.60 2.4867 .60800 
Valid N (list wise) 100     
 
Table 9: Table for Maternal Age, Gestational Age and   
Birth Weight of the New-born 
 
The maximum maternal age in years was 35 and minimum age was 18 
years with a mean of 24.88 and a standard deviation of 3.851. 
The lowest gestational age in weeks recorded was 29 and a highest of 41 
weeks with a mean of 36.44 and standard deviation of 2.709. 
Highest birth weight in Kg was 3.6 with a lowest of 0.98 kg. The mean 
was 2.4867 and a standard deviation of 0.608. 
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Table 10: Table for Gender-wise Maternal Age, 
Gestational Age and Birth Weight of the Newborn 
 
 
 
 
Gender of the Baby 
 
N 
 
Minimum 
 
Maximum 
 
Mean 
Std. 
Deviation 
BOYS 
Maternal 
Age  
(in years) 
 
60 
 
18 
 
35 
 
24.20 
 
3.931 
Gestational 
Age  
(in weeks) 
 
 
60 
 
 
30 
 
 
40 
 
 
36.47 
 
 
2.528 
Birth 
Weight 
(in kg) 
 
 
60 
 
 
1.10 
 
 
3.40 
 
 
2.4752 
 
 
.55721 
Valid N 
(list wise) 
 
60 
    
GIRLS 
Maternal 
Age  
(in years) 
40 20 34 25.90 3.536 
Gestational 
Age          
(in weeks) 
40 29 41 36.40 2.994 
Birth 
Weight     
(in kg) 
40 .98 3.60 2.5040 .68422 
Valid N 
(list wise) 40     
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Out of the 100 infants included in the study, 60 were males and the 
remaining 40 were females. The highest birth weight recorded among males 
was 3.4 kg with a lowest of 1.1 kg. The mean of birth weight in males was 
2.475 with a standard deviation of 0.55721. The highest gestational age in 
weeks was 40 with a lowest of 30 weeks. The mean gestational age was 36.47 
with a standard deviation of 2.528. 
 
The highest birth weight recorded among females was 3.6 kg with a 
lowest of 0.98 kg. The mean of birth weight in males was 2.504 with a standard 
deviation of 0.684221. The highest gestational age in weeks was 40 with a 
lowest of 29 weeks. The mean gestational age was 36.40 with a standard 
deviation of 2.994. 
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Chi- squared test analysis was used to determine whether the difference 
between expected and observed results is significant i.e. whether any difference 
is caused by chance or if another factor is affecting the results. In this case we 
check differences in expected and observed count of Maternal Malaria and we 
check if the variables Gender, Jaundice, Fever, Organomegaly and Gravida are 
the factors affecting Maternal Malaria. 
 
Here the Null hypothesis (H0) is: There is no significant statistical 
difference between the expected and observed results.  
 
In the following pages are the cross tabulations between each of the 
variables and Maternal Malaria. 
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Table 11 
Gender * Malaria Crosstabulation 
 
Chi-Square Tests 
 
 
 
 
 
 
 
Maternal Malaria 
Total 
Absent Present 
Gender 
Boy 
Count 57 4 61 
Expected Count 57.3 3.7 61.0 
Girl 
Count 37 2 39 
Expected Count 36.7 2.3 39.0 
Total 
Count 94 6 100 
Expected Count 94.0 6.0 100.0 
 Value Df Asymp. Sig. (2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .086a 1 .769   
Continuity Correctionb 
 
.000 1 1.000   
Likelihood Ratio .088 1 .767   
 
Fisher's Exact Test 
   1.000 .566 
 
N of Valid Casesb 
100     
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In the previous cross tabulation between gender and malaria (Table 
11), it can be observed that there is no significant difference between 
observed and expected count.  
 
Moving to the Chi- Square test table, 50% of the cells have 
expected count less than 5 which violates the Chi-square assumption, 
hence Pearson’s Chi-Square statistic is invalid. So we look at the 
Likelihood Ratio where the p value is 1 which is much higher than level 
of significance which is 0.05 thus we accept the null hypothesis that 
Gender of the child is not a factor effecting Maternal Malaria.  
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Table 12 
 
JAUNDICE * Malaria Crosstabulation 
 
   Maternal Malaria 
Total 
   Absent Present 
JAUNDICE 
Absent 
Count 88 5 93 
Expected Count 87.4 5.6 93.0 
Present 
Count 6 1 7 
Expected Count 6.6 .4 7.0 
Total 
Count 94 6 100 
Expected Count 94.0 6.0 100.0 
 
 
a. 1 cells (25.0%) have expected count less than 5. The minimum expected   
count is .42. 
b.   Computed only for a 2x2 table 
 
 
Value df Asymp. Sig. (2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 
 
.916a 1 .338   
Continuity Correctionb .017 1 .895   
 
Likelihood Ratio 
.694 1 .405   
 
Fisher's Exact Test 
   .361 .361 
 
N of Valid Casesb 
100     
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In the previous cross tabulation between Jaundice and Maternal Malaria 
(Table 12), it can be observed that there is no significant difference between 
observed and expected count.  
 
Moving to the Chi- Square test table 25.0% of the cells have expected 
count less than 5 which violates the Chi-square assumption, hence Pearson’s 
Chi-Square statistic is invalid. So we look at the Likelihood Ratio where the p 
value is 0.405 which is much higher than level of significance which is 0.05 
thus we accept the null hypothesis that Jaundice is not a factor effecting 
Maternal Malaria. 
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Table 13 
                                     FEVER * Malaria Cross tabulation 
 
 
Malaria 
Total 
Absent Present 
FEVER 
Absent 
Count 87 5 92 
Expected Count 86.5 5.5 92.0 
Present 
Count 7 1 8 
Expected Count 7.5 .5 8.0 
Total 
Count 94 6 100 
Expected Count 94.0 6.0 100.0 
 
Chi-Square Tests 
 
 Value df Asymp. Sig. (2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .651a 1 .420   
 
Continuity Correctionb 
.001 1 .975   
 
Likelihood Ratio 
.518 1 .471   
Fisher's Exact Test    .402 .402 
N of Valid Casesb 100     
 
a. 1 cells (25.0%) have expected count less than 5. The minimum expected 
count      
is .48. 
b. Computed only for a 2x2 table 
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In the previous cross tabulation between Fever and Maternal Malaria 
(Table 13), it can be observed that there is no significant difference between 
observed and expected count.  
 
Moving to the Chi- Square test table 25.0% of the cells have expected 
count less than 5 which violates the Chi-square assumption, hence Pearson’s 
Chi-Square statistic is invalid. So we look at the Likelihood Ratio where the p 
value is 0.471 which is much higher than level of significance which is 0.05 
thus we accept the null hypothesis that Fever is not a factor effecting Maternal 
Malaria.  
 
 
  
 
 
- 73 - 
 
Table 14 
 
 
ORGANOMEGALY * Malaria Crosstabulation 
 
 
   Malaria 
Total 
   Absent Present 
ORGANOMEGALY 
Absent 
Count 90 5 95 
Expected Count 89.3 5.7 95.0 
Present 
Count 4 1 5 
Expected Count 4.7 .3 5.0 
Total 
Count 94 6 100 
Expected Count 94.0 6.0 100.0 
 
Chi-Square Tests 
 
 Value df Asymp. Sig. (2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 
 
1.829a 1 .176   
Continuity Correctionb .149 1 .699   
 
Likelihood Ratio 
1.213 1 .271   
 
Fisher's Exact Test 
   .271 .271 
 
N of Valid Casesb 
100     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .30. 
b. Computed only for a 2x2 table    
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In the previous cross tabulation between Organomegaly  and Maternal 
Malaria (Table 14), it can be observed that  there is no significant difference 
between observed and  expected count.  
 
Moving to the Chi- Square test table 50.0% of the cells have expected 
count less than 5 which violates the Chi-square assumption, hence Pearson’s 
Chi-Square statistic is invalid. So we look at the Likelihood Ratio where the p 
value is 0.271 which is much higher than level of significance which is 0.05 
thus we accept the null hypothesis that Organomegaly is not a factor effecting 
Maternal Malaria. 
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                                                     Table 15 
 
ANAEMIA * Malaria Cross tabulation 
 
   Malaria 
Total 
   Absent Present 
ANAEMIA 
Absent 
Count 84 6 90 
Expected Count 84.6 5.4 90.0 
Present 
Count 10 0 10 
Expected Count 9.4 .6 10.0 
Total 
Count 94 6 100 
Expected Count 94.0 6.0 100.0 
 
Chi-Square Tests 
 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 
 
.709a 1 .400 
  
Continuity Correctionb .020 1 .888   
 
Likelihood Ratio 
1.306 1 .253 
  
 
Fisher's Exact Test 
   
1.000 .522 
 
N of Valid Casesb 
100 
    
 
a. 1 cells (25.0%) have expected count less than 5. The minimum expected 
count is .60. 
b. Computed only for a 2x2 table 
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   In the previous cross tabulation between anaemia and maternal malaria 
(Table 15), it can be observed that there is no significant difference between 
observed and expected count.  
 
Moving to the Chi- Square test table 25.0% of the cells have expected 
count less than 5 which violates the Chi-square assumption, hence Pearson’s 
Chi-Square statistic is invalid. So we look at the Likelihood Ratio where the p 
value is 0.253 which is much higher than level of significance which is 0.05 
thus we accept the null hypothesis that anaemia is not a factor effecting 
Maternal Malaria. 
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DISCUSSION 
 
 
 
The true incidence of congenital malaria remained a controversial issue 
for many years as many had reported it being an infrequent occurring. (9) 
 
However, some studies conducted across Africa have brought to light 
that its occurrence was not so rare as was previously considered.  
 
Pregnant women are more prone to malaria infection. (26) 
 
As such maternal malaria has been known to have an adverse impact on 
the health of the newborn. (27) 
 
Many studies have been conducted across the globe for reporting the 
incidence of cord blood parasitaemia in infants in malaria endemic zones.  
 
Studies done across Africa have reported P. falciparum as the main 
causative agent. (WHO 2000) 
 
In similar studies from India and a few Asian countries P. Vivax was the 
most common agent causing congenital malaria. (28) 
 
Peripheral blood smears from placental, neonatal and cord blood have 
been used to look for malarial parasite.  
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The various studies done across have shown prevalence rates of  
0 – 30%. (7) 
 
 
In our study we have tried to study the prevalence of cord blood 
parasitaemia in infants in malaria endemic zone by examining the smears 
prepared from cord blood.  
 
No case of congenital malaria could be detected using this technique 
during the entire study period. 
 
 
A number of recent studies done across Africa reported congenital 
malaria as an infrequent occurring .The occurrence of cord or neonatal blood 
parasitaemia was found to be insignificant. Rare instances of few newborns 
developing the disease, during the initial weeks of life, have been shown. 
 
The placenta has been shown to have a remarkable tendency and has 
been an effective barrier to restrict the passage of malarial parasite to the 
foetus. 
 
The foetus too has a remarkable capacity to resist infection responsible 
for congenital malaria. (10)  
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               A study was done in the hyper endemic region in the state of Madhya 
Pradesh. J. Singh et al had reported very low incidence of congenital malaria 
despite high prevalence of maternal malaria and emphasized on the need to 
conduct more studies in Indian setup. (7) 
 
              Similar study done in Central India by N.Singh et al reported higher  
prevalence  of maternal malaria. (26) 
 
 
The study did not report any prevalence of congenital malaria even 
though all symptomatic cases and those with maternal parasitaemia were 
followed up with repeat smears. 
 
There were however many limitations in the study.  
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LIMITATIONS OF THE STUDY 
 
 
 The sample size of the study was small.  
 It was conducted over a short period of time. 
 Only peripheral smears prepared from cord blood were used to 
determine the presence of malarial parasites. 
 The study did not incorporate other modalities like  rapid diagnostic 
tests.  
 Samples were neither drawn from all the babies (only the subsequently 
followed up ones) nor from the placenta for peripheral smear 
examination. 
 
 The study registered only babies of mothers with  history of fever. 
 
 
 Also, the histopathological examination of the placenta, counted to be a 
further dependable technique of evaluating placental infection than 
considering only peripheral blood smears, was not done. 
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A number of factors have been reported to influence its estimation 
which include: 
 
 difference in understanding the criteria for defining congenital malaria; 
 
 resistance of mothers to infection; 
 
 source from where the blood samples were taken for smear examination 
(neonatal or cord blood);  
 the experience and reliability of peripheral smear 
 
examinations by the trained medical personnel;  
 
 the technique used for parasite detection 
 (Giemsa staining with smear examination or  PCR). (12) 
 
 
 
Failure to consider these factors could lead to its underestimation. 
Therefore, these influencing factors must be taken into consideration so as to 
avoid the false and inadequate estimation of its prevalence. (12)  
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A current Western Kenyan study discovered that by microscopy, the 
prevalence of placental infections was about seventeen percent and that of cord 
blood infections was zero percent, but by PCR technique, the prevalence was 
about thirty-three percent and almost eleven percent respectively. (29) 
 
The findings prove that malaria diagnosis is commonly missed in 
newborns when microscopy is employed. The earlier estimate of prevalence of 
congenital malaria may have been under-reported owing to the inadequate 
sensitivity of light microscopy. 
 
 
Repeat smear examination may be necessary to detect malarial 
parasitaemia.  
 
 
Researchers in Turkey reported congenital malaria only after they were 
able to isolate the organism in repeat peripheral blood smears. (30)  
 
 
A single blood smear in absence of parasitaemia is not sufficient to rule 
out malaria. (31) 
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Congenital malaria happened to get detected accidentally in a case in 
India showing no apparent symptoms. (32) 
 
Due to shortage of precise symptoms, many cases of congenital malaria 
have been mistaken for sepsis or infections such as TORCH and syphilis (33).  
 
 
A good clinical examination and follow-up, a high index of suspicion 
and a peripheral blood smear examination by an experienced personnel is 
essential for the accurate diagnosis of congenital malaria. 
 
The detection of the parasite may require repeat peripheral blood smear 
examination. 
 
Thereby, detection of plasmodial antigen or PCR of the blood may be 
employed in addition to enhance case detection rate. (29) 
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CONCLUSION 
 
The study was conducted at a tertiary centre in malaria endemic zone. 
 
Infants with history of maternal fever were included in the study.  
 
Peripheral smears were prepared from the cord blood to look for malaria 
parasite.  
The study has reported a negative prevalence of congenital malaria.  
 
The result of this study and previous other studies indicate a low 
prevalence of congenital malaria.  
 
A total of six cases of maternal parasitaemia was found in the study.  
The cord blood parasitaemia could not be demonstrated in their infants  
(Pie Chart 1).  
As demonstrated in Figure 10, few infants, however did show some 
symptoms despite a negative smear report.   
 A few of them presented with fever, anaemia, jaundice and 
organomegaly which was later evaluated for some other medical conditions.  
 
 
 
- 85 - 
 
A repeat peripheral smear was also done for them but it failed to 
demonstrate any parasite.  
Anaemia was more common in preterms.  
 
3 infants out of 6 with positive maternal malaria were of  
low birth weight.  
 
Also the gestational ages were found to be less than 37 weeks in them.  
 
However, the limitations of the study should also be taken into account.  
 
Many studies done across have reported very less or no prevalence of 
cord blood parasitaemia.  
 
Likewise, a recent study done in Kenya reported a no prevalence of cord 
blood parasitaemia when done using microscopy. A total of nearly 11% of 
cases were detected as positive when PCR was done in the same population. 
 
The findings prove that malaria diagnosis is commonly missed in 
newborns when microscopy is employed. The former estimate of prevalence of 
congenital malaria may have been under-reported owing to the inadequate 
sensitivity of light microscopy. 
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Repeat smear examination may be necessary as a study done in Turkey 
was able to detect parasites only when the smears were repeated.  
  
The study has reported no case of congenital malaria.  
 
 
We conclude that cord blood parasitaemia estimation is not a very 
reliable method when used alone.    
 
Diagnostic modalities such as PCR, histopathological examination of 
the placenta and other newer rapid diagnostic tests could also have been used in 
addition.  
 
Therefore, there is a need to conduct more studies in the Indian setup 
using different modalities combined.  
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Pie Chart 1 
A total of 9 cases of maternal parasitaemia was found in the study out of 
the 100 maternal fever cases observed. 
 
 
 
 
 
 
However, the cord blood parasitaemia could not be demonstrated in 
their infants. 
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Figure 10 
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- 89 - 
 
SUMMARY 
 
 
 Various studies have concluded that congenital malaria is not as 
infrequent as was formerly speculated. 
 
 A close connection between placental parasitaemia and cord blood 
parasitaemia is accountable for congenital malaria. 
 
 The study did not detect any cord blood parasitaemia. 
 
 Many studies done across have reported very less or no prevalence 
of cord blood parasitaemia despite high maternal parasitaemia. 
 
 A zero percent prevalence of cord-blood parasitaemia was reported in a 
study when done using microscopy. PCR detected nearly eleven percent 
cases positive in the same population. 
 
 Repeat smear examination may be necessary to detect parasitaemia. 
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 Diagnostic modalities such as PCR, histopathological examination of 
the placenta and newer rapid diagnostic tests could also have been used 
in addition.  
 
 Therefore, there is a need to conduct more studies in the Indian setup 
using different modalities combined.  
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ABBREVIATIONS 
PCR   Polymerase chain reaction 
Hb   Haemoglobin 
HPE   Histopathological examination    
WHO   World Health Organization 
CS PROTIEN Circumsporozoite protien 
HIV   Human immunodeficiency virus 
RDT   Rapid diagnostic test   
EDTA  Ethylene Diamine TetraAcetic acid 
WBC   White blood cells 
LBW   Low birth weights 
AIDS   Acquired immunodeficiency syndrome 
RBC   Red Blood Cells 
  
 
 
 
 
 
 
 
 
 
                                     INFORMATION SHEET 
 
 
Place of study: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR CHILDREN / 
INSTITUTE OF GYNAECOLOGY, EGMORE,CHENNAI-8. 
Name of Investigator :Dr.CHEWANG DORJEE BHUTIA 
Name of Participant    age:   sex:  
Hospital No:      
Study title:”Prevalance of cord blood parasitaemia & its impact in the health of 
newborns” Cord blood samples will be collected at the time of delivery. 
  Blood smears will be prepared& examined for presence of malarial parasites. 
  Newborns of smear positive cases will be assessed & followed up. 
  No blood samples will be drawn. They will be clinically examined for organomely, 
fever ,jaundice , anaemia, weight monitored & nutritional status assessed. 
The privacy of the patients in the research will be maintained throughout the study. 
Inthe event of any publication or presentation resulting from the research, no 
personallyidentifiable information will be shared. 
 
Taking part in this study is voluntary. You are free to decide whether to participate 
inthis study or to withdraw at any time; your decision will not result in any loss ofbenefits to 
which you are otherwise entitled. 
 
The results of the special study may be intimated to you at the end of the study 
periodor during the study if anything is found abnormal which may aid in the managementor 
treatment. 
 
Signature of investigator.     Signature of 
parent/guardian. 
 
Date: 
 
 
 
INFORMED CONSENT FORM 
 
Study place: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR CHILDREN / 
INSTITUTE of GYNAECOLOGY, EGMORE,CHENNAI-8. 
Title of the study :“PREVALANCE OF CORD BLOOD PARASITAEMIA & ITS IMPACT 
IN THE HEALTH OF NEWBORN.” 
Name of the investigator:Dr. CHEWANG DORJEE BHUTIA    
  
Name of the Participant: Age:   Sex: 
Hospital number:   
 
1.  I have read and understood this consent form and the information provided to me 
regarding the participation of my child in the study.  
2.  I have had the consent document explained to me.  
3.  I have been explained about the nature of the study.  
4.  I have been explained about my rights and responsibilities by the investigator. 
5. I will allow my child to undergo clinical tests subjected during the study whole heartedly. 
6.  I will allow my child to cooperate with the investigator through out the study. 
7.  I have been advised about the risks associated with my child’s participation in this study.* 
8.  I agree that my child will cooperate with the investigator and I will inform him/her 
immediately if my child suffer from  some problem during the study. * 
9.  My childhave not participated in any research study in the past. 
10.  I am aware of the fact that I can opt out of the study at any time without having to give 
any reason and this will not affect my child’s future treatment in this hospital. * 
11.  I am also aware that the investigator may terminate mychild’s  participation in the study 
at any time, for any reason, without my consent. * 
12.  I hereby give permission to the investigators to release the information obtained from my 
child as result of participation in this study to the sponsors, regulatory authorities, Govt. 
agencies, and IEC. I understand that they are publicly presented. 
13.  I have understand that  my child’s identity will be kept confidential if my child’s data are 
publicly presented  
14. I have had my questions answered to my satisfaction.  
 
 
 
15. I have decided my child can beparticipated in the research study.  
I am aware that if I have any question during this study, I should contact the investigator. 
By signing this consent form I attest that the information given in this document has been 
clearly explained to me and understood by me, I will be given a copy of this consent 
document. 
Name and signature / thumb impression of the parents/guardian  
Name _________________________ Signature_________________ 
Date________________  
Name and Signature of impartial witness:  
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of the investigator or his representative obtaining consent:  
Name _________________________ Signature_________________ 
Date________________  
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
Data collection sheet 
 
Name :                                                                  Maternal age :  
Maternal fever :                                            
Gravida : 
Ip no :                                         
Address : 
 
Maternal malaria : Yes/No 
CORD BLOOD FOR MALARIAL PARASITE :    Positive 
/Negative 
Newborn  
          Birth Weight  :   (in kg )                      
          Sex of the child :   Boy/girl 
          Gestational age  :   (in weeks) 
Symptoms in newwborns 
         Organomegaly :   Yes/No 
          Jaundice   :   Yes/No 
          Anaemia   :   Yes/No 
          Fever    :   Yes/No 
 
Repeat peripheral smear examination (done for symptomatic 
cases) : 
                            Positive / Negetive 
 
 
 
 
NAME MATENAL AGE (in yrs) 
MATERNAL 
FEVER GRAVIDA 
CORD BLOOD 
PARASITAEMIA 
MATERNAL 
MALARIA 
GESTATION( 
in weeks) 
BIRTH 
WEIGHT(in 
kg) 
JAUNDICE FEVER ORGANOMEGALY ANAEMIA GENDER 
INFANTS 
FOLLOWED 
UP 
B/o Saranya 21 yes  PRIMI NEGATIVE NEGATIVE 38 2.7 absent present absent absent boy YES 
B/o Indumathy 21 yes  PRIMI NEGATIVE NEGATIVE 37 2.84 absent absent absent present boy YES 
B/o Khushboo 20 yes  PRIMI NEGATIVE POSITIVE 35 2.1 absent absent absent absent boy YES 
B/o Thilagavathy 21 yes  PRIMI NEGATIVE NEGATIVE 39 3.1 absent absent absent absent girl NO 
B/o Jeevalakshmi 30 yes  G3P2L1 NEGATIVE NEGATIVE 36 2.4 absent absent absent absent girl NO 
B/o Ranjitha 25 yes  G2P1L1 NEGATIVE NEGATIVE 33 1.9 absent absent absent present girl YES 
B/o Vijaya 23 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.75 absent absent absent absent boy NO 
B/o Vinodhini 23 yes  PRIMI NEGATIVE NEGATIVE 39 2.6 absent absent absent absent boy NO 
B/o Marthammal 32 yes  G3P2L2 NEGATIVE POSITIVE 32 1.4 absent absent absent absent girl YES 
B/o Jayalitha 22 yes  PRIMI NEGATIVE NEGATIVE 34 1.98 absent present absent absent boy YES 
B/o Karpagan 20 yes  PRIMI NEGATIVE NEGATIVE 36 2.4 absent absent absent absent girl NO 
B/o Abirami 26 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.9 absent absent absent absent boy NO 
B/o Kowshika Devi 27 yes  G2P1L1 NEGATIVE NEGATIVE 39 3.1 absent absent absent present girl YES 
B/o Nagavalli 19 yes  PRIMI NEGATIVE NEGATIVE 37 2.45 absent absent absent absent boy NO 
B/o Nancy 28 yes  G3P2L2 NEGATIVE NEGATIVE 30 1.2 absent absent absent present girl YES 
B/o Sarala 34 yes  G4P3L2 NEGATIVE NEGATIVE 38 2.56 absent absent absent absent girl NO 
B/o Chinishyala 32 yes  G4P3L2 NEGATIVE NEGATIVE 39 2.8 absent absent absent absent boy NO 
 
 
 
B/o Malar 22 yes  PRIMI NEGATIVE NEGATIVE 36 2.52 absent present present absent boy YES 
B/o Abina Begum 22 yes  PRIMI NEGATIVE NEGATIVE 38 2.3 absent present absent absent boy YES 
B/o Anitha 27 yes  G2P1L1 NEGATIVE NEGATIVE 33 1.7 present absent absent absent girl YES 
B/o Lavanya 23 yes  G2P1L1 NEGATIVE NEGATIVE 31 1.3 absent absent absent absent boy NO 
B/o Thanagamani 21 yes  PRIMI NEGATIVE NEGATIVE 38 2.7 absent absent absent absent boy NO 
B/o Parameshwari 22 yes  PRIMI NEGATIVE NEGATIVE 33 1.6 present absent present absent boy YES 
B/o Swathi 20 yes  PRIMI NEGATIVE NEGATIVE 37 2.68 absent absent absent absent boy NO 
B/o Gowthami 24 yes  G2P1L1 NEGATIVE NEGATIVE 37 3.2 absent absent absent absent boy NO 
B/o Mahalakshmi 26 yes  G2P1L1 NEGATIVE NEGATIVE 37 3.1 absent absent absent absent boy NO 
B/o Brinda 28 yes  G3P2L2 NEGATIVE NEGATIVE 36 3 absent absent absent absent boy NO 
B/o Jayashree 29 yes  G3P2L2 NEGATIVE NEGATIVE 37 2.2 absent absent absent absent boy NO 
B/o Sathya 23 yes  G2P1L1 NEGATIVE NEGATIVE 39 3.4 absent absent absent absent boy NO 
B/o Mahalakshmi 26 yes  G2P1L1 NEGATIVE NEGATIVE 38 3.2 absent absent absent absent girl NO 
B/o Kanaga Durga 21 yes  PRIMI NEGATIVE NEGATIVE 38 2.8 absent absent absent absent boy NO 
B/o Bharathi 20 yes  PRIMI NEGATIVE NEGATIVE 37 2.45 absent absent absent absent boy NO 
B/o Amalavathy 25 yes  G2P1L1 NEGATIVE NEGATIVE 34 2.5 absent absent absent absent boy NO 
B/o Revathy 25 yes  G2P1L1 NEGATIVE NEGATIVE 35 2.15 present absent absent absent girl YES 
B/o Nathiya 28 yes  G3P2L2 NEGATIVE NEGATIVE 37 2.54 absent absent absent absent boy NO 
B/o Gowri 35 yes  G3P2L2 NEGATIVE NEGATIVE 39 2.7 absent present absent absent boy YES 
B/o Arulmozhi 30 yes  PRIMI NEGATIVE NEGATIVE 39 2.9 absent absent absent absent girl NO 
B/o Shanthi 30 yes  G3P2L2 NEGATIVE NEGATIVE 35 2.25 absent absent absent absent boy NO 
B/o Bakiyalakshmi 23 yes  PRIMI NEGATIVE POSITIVE 38 2.7 absent absent absent absent boy YES 
 
 
 
B/o Rajeshwari 34 yes  G4P3L1 NEGATIVE POSITIVE 35 2.1 absent absent absent absent boy YES 
B/o Nazra Begum 24 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.98 absent absent absent absent girl NO 
B/o Christina Mary 22 yes  PRIMI NEGATIVE NEGATIVE 38 3 absent absent absent absent girl NO 
B/o Hemalatha 22 yes  G2P1L1 NEGATIVE NEGATIVE 32 1.4 absent absent absent present boy YES 
B/o Chitra Devi 32 yes  G3P1L1A1 NEGATIVE NEGATIVE 32 1.35 absent absent absent present girl YES 
B/o Kumari 25 yes  G2PILI NEGATIVE NEGATIVE 37 2.3 absent absent absent absent boy NO 
B/o Devi 23 yes  PRIMI NEGATIVE NEGATIVE 36 2.4 absent absent absent absent boy NO 
B/o Umashankari 25 yes  G2P1L1 NEGATIVE NEGATIVE 37 2.45 absent absent absent absent girl NO 
B/o Jayanthi 24 yes  PRIMI NEGATIVE NEGATIVE 31 1.2 absent present absent absent boy YES 
B/o Saranya 27 yes  G3P2L1 NEGATIVE NEGATIVE 30 1.1 absent absent absent absent boy NO 
B/o Hemapriya 23 yes  PRIMI NEGATIVE NEGATIVE 29 0.98 absent absent absent absent girl NO 
B/o Punitha 23 yes  G2P1L1 NEGATIVE NEGATIVE 38 3.3 absent absent absent absent boy NO 
B/o Rajakumari 20 yes  PRIMI NEGATIVE NEGATIVE 38 3.1 absent absent absent absent boy NO 
B/o Subhashini 20 yes  PRIMI NEGATIVE NEGATIVE 35 2.2 present absent present absent girl YES 
B/o Geetha 22 yes  PRIMI NEGATIVE NEGATIVE 36 2.4 absent absent absent absent boy NO 
B/o Vijayasri 23 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.7 absent absent absent absent boy NO 
B/o Gomathy 23 yes  G2P1L1 NEGATIVE NEGATIVE 34 2.1 absent absent absent absent girl NO 
B/o Payal 18 yes  PRIMI NEGATIVE POSITIVE 37 2.5 absent absent absent absent boy YES 
B/o Rajeshwari 22 yes  PRIMI NEGATIVE NEGATIVE 38 3.1 absent absent absent absent girl NO 
B/o Vidhya 23 yes  PRIMI NEGATIVE NEGATIVE 37 2.4 absent absent absent absent boy NO 
B/o Megha 29 yes  G2P1L1 NEGATIVE NEGATIVE 37 2.45 absent absent absent absent boy NO 
B/o Meera 25 yes  G2P1L1 NEGATIVE NEGATIVE 39 3.4 absent absent absent absent girl NO 
 
 
 
B/o Menuka 24 yes  G2P1L1 NEGATIVE NEGATIVE 39 3.1 absent absent absent absent girl NO 
B/o Gowthami 27 yes  PRIMI NEGATIVE NEGATIVE 37 3 absent absent absent absent girl NO 
B/o Gowri 28 yes  G3P2L1 NEGATIVE NEGATIVE 39 3.6 absent absent absent absent girl NO 
B/o Saraswati  22 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.89 absent absent absent absent girl NO 
B/o Chitra 23 yes  PRIMI NEGATIVE NEGATIVE 39 2.68 absent absent absent absent boy NO 
B/o Rani 27 yes  PRIMI NEGATIVE NEGATIVE 38 2.45 absent absent absent absent boy NO 
B/o Bhuvaneshwari 26 yes  G2P1L1 NEGATIVE NEGATIVE 39 3 absent absent absent absent boy NO 
B/o Arulmozhi 29 yes  G2P1L1 NEGATIVE NEGATIVE 40 3.2 absent absent absent absent girl NO 
B/o Kavitha 28 yes  G3P2L2 NEGATIVE NEGATIVE 30 1.3 absent absent absent absent girl NO 
B/o Deepa 22 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.7 absent absent absent absent boy NO 
B/o Yazhimozhi 30 yes  G3P1L1A1 NEGATIVE NEGATIVE 37 2.4 absent absent absent absent girl NO 
B/o Jenith 28 yes  G2P1L1 NEGATIVE NEGATIVE 39 3.2 absent absent absent absent girl NO 
B/o Ajitha 22 yes  PRIMI NEGATIVE NEGATIVE 36 2.39 absent absent absent absent boy NO 
B/o Narmada 26 yes  PRIMI NEGATIVE NEGATIVE 35 2.6 absent absent absent absent boy NO 
B/o Lakshmi 23 yes  G2P1L1 NEGATIVE NEGATIVE 38 3 absent absent absent absent girl NO 
B/o Pooja 22 yes  PRIMI NEGATIVE NEGATIVE 36 2.5 absent absent absent absent boy NO 
B/o Srija 19 yes  PRIMI NEGATIVE NEGATIVE 34 2.4 absent absent absent absent boy NO 
B/o Jayanthy 21 yes  PRIMI NEGATIVE NEGATIVE 37 2.3 absent absent absent absent boy NO 
B/o Abirami 28 yes  G3P2L2 NEGATIVE NEGATIVE 37 2.45 absent absent absent absent girl NO 
B/o Abinaya 27 yes  G3P2L2 NEGATIVE NEGATIVE 34 2.2 absent absent absent absent girl NO 
B/o Menuga 31 yes  G2P1L1 NEGATIVE NEGATIVE 40 3.3 absent absent absent absent boy NO 
B/o Jenny 30 yes  G3P1L1A1 NEGATIVE NEGATIVE 40 3.1 absent absent absent absent boy NO 
 
 
 
B/o Damyanthy 22 yes  PRIMI NEGATIVE NEGATIVE 37 2.2 absent absent absent absent girl NO 
B/o Dhaarani 20 yes  PRIMI NEGATIVE NEGATIVE 37 2.48 absent absent absent absent boy NO 
B/o Sujitha 30 yes  G2P1L1 NEGATIVE NEGATIVE 41 3.1 absent absent absent absent girl NO 
B/o Suganya 26 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.8 absent absent absent absent girl NO 
B/o Ranjita 23 yes  G2P1L1 NEGATIVE NEGATIVE 37 2.4 present absent absent present boy YES 
B/o Tasleem Begum 29 yes  G3P2L2 NEGATIVE POSITIVE 37 2.5 absent absent absent absent boy YES 
B/o Yaalani 32 yes  G3P1L1A1 NEGATIVE NEGATIVE 30 1.2 absent absent absent absent boy NO 
B/o Kavya 27 yes  PRIMI NEGATIVE NEGATIVE 33 1.5 present absent present present girl YES 
B/o Rekhashree 23 yes  PRIMI NEGATIVE NEGATIVE 32 1.45 absent absent absent present boy YES 
B/o Jeevashree 22 yes  PRIMI NEGATIVE NEGATIVE 36 2.2 absent present absent absent girl YES 
B/o Sree Devi 29 yes  G2P1L1 NEGATIVE NEGATIVE 38 2.5 absent absent absent absent boy NO 
B/o Hema 20 yes  PRIMI NEGATIVE NEGATIVE 37 2.35 absent absent absent absent girl NO 
B/o Christine 27 yes  G2P1L1 NEGATIVE NEGATIVE 39 3 absent absent absent absent girl NO 
B/o Sajeeta Begum 21 yes  PRIMI NEGATIVE NEGATIVE 37 3.4 absent absent absent absent boy NO 
B/o Jenifer 22 yes  PRIMI NEGATIVE NEGATIVE 39 2.75 absent absent absent absent boy NO 
B/o Poornika 22 yes  PRIMI NEGATIVE NEGATIVE 38 2.8 absent present absent absent boy YES 
B/0 Pongodi 27 yes  G2P1L1 NEGATIVE NEGATIVE 36 2.4 present absent present present girl YES 
 
